Study of gender difference of opportunistic infections in AIDS patients
Abstract
Introduction: Concerns about sex-based differences in the course of HIV infection were expressed early in the epidemic. Women appeared to have more rapid progression of illness than men and to present with a different constellation of opportunistic infections than men. Conducting sex comparisons within research studies is important to delineate sex differences or similarities.
Material & Methods: A prospective cohort study involving HIV infected patients scheduled to start ART, in which 156 male, 82 female and 1 transgender was undertaken to compare the gender difference in age distribution, marital status, presenting symptoms .Structured questionnaires and patients file review were used to collect. data through history, physical ex:amination and laboratory investigations. Gender differences were assessed using chi-square test for categorical data.
Results: In the study population 239 patients who fulfilled NACO guidelines for AIDS were included, 156 men and 82 women. Fever was the commonest presenting symptom (57.32%) in both males and females, 61.53% of males and 48.78% females presented with fever. The most frequent AIDS Defining Infections were tuberculosis (42.25%) and candidiasis (22.6%). Pulmonary Tuberculosis, Tubercular meningitis were significantly higher in males compared to females. Herpes simplex (P value 0.007) and non specific dermatitis showed statistically significantly higher in females compared to males in occurrence rate.
Conclusion: Evaluation of differences between human immunodeficiency virus (HIV)-infected men and women in antiretroviral therapy (ART) enrollment characteristics and outcomes might identify opportunities to improve ART program, patient outcomes and prevention impact. We studied gender differences in opportunistic infections in AIDS patient.
Downloads
References
2. Cornell M, Schomaker M, Garone D. Gender differences in survival among adult patients starting antiretroviral therapy in south Africa: a multicentre cohort study. PLOS Medicine. 2012;9:e1001304. doi: 10.1371/journal.pmed.1001304.
3. Maman D, Pujades-Rodriguez M, Subtil F. Gender differences in immune reconstitution: a multicentric cohort analysis in sub-Saharan Africa. PLoS One. 2012;7(2):e31078. doi: 10.1371/journal.pone.0031078.
4. Brown T. and Peerapatanapokin W.: The Asian Epidemic Model: A process model for exploring HIV policy and programme alternatives in Asia. Sex Transm Infect 2004;80(Suppl 1):i19– 24. [PubMed]
5. Amin A Addressing gender inequalities to improve the sexual and reproductive health and wellbeing of women living with HIV. J Int AIDS Soc. 2015 Dec 1; 18(Suppl 5):20302. Epub 2015 Dec 1. [PubMed]
6. Beckham SW, Beyrer C, Luckow P, Doherty M, Negussie EK, Baral SD. Journal of the International AIDS Society. 2016 Nov 8; 19(1): 21106. [PubMed]
7. NACO (2015) ‘Annual report 2015 -16’ www.naco.org
8. NACO (2015) ‘Narrative country progress report of India: Global AIDS Response Progress Reporting 2015’ www.unaids.org
9. Kumarasamy N. Chagututu S. Mayer KH, et al. Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India. J Acquir Immune Defic Syndr. 2004;37:1574–1576.
10. Lawn S. Badri M. Wood R. Tuberculosis among HIV-infected patients receiving HAART: Long-term incidence and risk factors in a South African cohort. AIDS. 2005;19:2109–2116. [PubMed]
11. UNAIDS. UNAIDS/WHO AIDS epidemic update. www.unaids.org/epidemic-update/ [Aug 9;2007 ]. www.unaids.org/epidemic-update.
12. Gandhi M. Aweeka F. Greenblatt RM. Blasche TF. Sex differences in pharmacokinetics and pharmacodynamics. Ann Rev Pharmacol Toxicol. 2004;44:499–523. [PubMed]
13. Gandhi M. Bacchetti P. Miotti P. Quinn TC. Veronese F. Greenblatt RM. Does patient sex affect human immunodeficiency virus levels? Clin Infect Dis. 2002;35:313–322. [PubMed]
14. Mocroft A. Gill MJ. Davidson W. Phillips AN. Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? J Acquir Immune Defic Synd. 2000;24:475–482.
15. Sterling T. Vlahov D. Astemborski J. Hoover DR. Margolick J. Quinn TC. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med. 2001;344:720–725. [PubMed]
16. Moore A. Kirk O. Johnson AM, et al. Virologic, immunologic, and clinical response to highly active antiretroviral therapy: The ender issues revisited. J Acquir Immune Defic Synd. 2003;32:452–461.
17. Newmann S. Sarin P. Kumarasamy N, et al. Marriage, monogamy and HIV: A profile of HIV-infected women in south India. Int J STD AIDS. 2000;11:250–253. [PubMed]
18.WHO. Summary country profile for HIV/AIDS treatment scale-up: India. [Jul 24;2007 ]. www.who.int/hiv/HIVCP_IND.pdf
19. Rogers A. Meundi A. Amma A, et al. HIV-related knowledge, attitudes, perceived benefits, and risks of HIV testing among pregnant women in rural southern India. AIDS Patient Care STDs. 2006;20:803–811.
20. Reed E, Fisher CB, Blankenship KM, West BS, Khoshnood K Why female sex workers participate in HIV research: the illusion of voluntariness.AIDS Care. 2016 Dec 28:1-5. [PubMed]
21. Kumarasamy N. Chagututu S. Mayer KH, et al. Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India. J Acquir Immune Defic Syndr. 2004;37:1574–1576.
22. Lawn S. Badri M. Wood R. Tuberculosis among HIV-infected patients receiving HAART: Long-term incidence and risk factors in a South African cohort. AIDS. 2005;19:2109–2116.
23. N. Kumarasamy K.K. Venkatesh, Gender-Based Differences in Treatment and Outcome among HIV Patients in South India J Womens Health (Larchmt). 2008 Nov; 17(9): 1471–1475.
OAI - Open Archives Initiative
